168 related articles for article (PubMed ID: 38571432)
1. Precision Endpoints for Contemporary Precision Oncology Trials.
Hoo R; Chua KLM; Panda PK; Skanderup AJ; Tan DSW
Cancer Discov; 2024 Apr; 14(4):573-578. PubMed ID: 38571432
[TBL] [Abstract][Full Text] [Related]
2. Community-driven development of a modified progression-free survival ratio for precision oncology.
Mock A; Heilig CE; Kreutzfeldt S; Huebschmann D; Heining C; Schröck E; Brors B; Stenzinger A; Jäger D; Schlenk R; Glimm H; Fröhling S; Horak P;
ESMO Open; 2019; 4(6):e000583. PubMed ID: 31798980
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
4. Significance of emerging clinical oncology endpoints in support of overall survival.
Patil S; Agarwal V; Drupad HS
Indian J Cancer; 2022 Mar; 59(Supplement):S106-S118. PubMed ID: 35343195
[TBL] [Abstract][Full Text] [Related]
5. Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.
Anagnostou V; Yarchoan M; Hansen AR; Wang H; Verde F; Sharon E; Collyar D; Chow LQM; Forde PM
Clin Cancer Res; 2017 Sep; 23(17):4959-4969. PubMed ID: 28864724
[TBL] [Abstract][Full Text] [Related]
6. RECISTv1.1 progression in oncology: Shades of gray.
Topp B; Snyder A; Wolchok J
Cancer Cell; 2023 Jun; 41(6):1003-1005. PubMed ID: 37172579
[TBL] [Abstract][Full Text] [Related]
7. Molecular Target and Action Mechanism of Anti-Cancer Agents.
Lee SG
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175963
[TBL] [Abstract][Full Text] [Related]
8. Precision Oncology: 2023 in Review.
Murciano-Goroff YR; Suehnholz SP; Drilon A; Chakravarty D
Cancer Discov; 2023 Dec; 13(12):2525-2531. PubMed ID: 38084089
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine strategies in oncology: mixed approaches to matched therapies.
Borcoman E; Le Tourneau C
Future Oncol; 2018 Jan; 14(2):105-109. PubMed ID: 29224361
[No Abstract] [Full Text] [Related]
10. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
11. Ushering in the next generation of precision trials for pediatric cancer.
DuBois SG; Corson LB; Stegmaier K; Janeway KA
Science; 2019 Mar; 363(6432):1175-1181. PubMed ID: 30872517
[TBL] [Abstract][Full Text] [Related]
12. What is the expected benefit of patient-centric clinical development in oncology?
Serra A; Mozgunov P; Jaki T; Rigat F
J Biopharm Stat; 2022 May; 32(3):414-426. PubMed ID: 35848802
[TBL] [Abstract][Full Text] [Related]
13. Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation.
Wheaton L; Papanikos A; Thomas A; Bujkiewicz S
Med Decis Making; 2023 Jul; 43(5):539-552. PubMed ID: 36998240
[TBL] [Abstract][Full Text] [Related]
14. Endpoints in clinical trials for liver cancer and their value in evidence-based clinical decision making: An unresolved Gordian knot.
Bruix J
J Hepatol; 2021 Jun; 74(6):1483-1488. PubMed ID: 33556420
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.
Shi Q; Sargent DJ
Int J Clin Oncol; 2009 Apr; 14(2):102-11. PubMed ID: 19390940
[TBL] [Abstract][Full Text] [Related]
16. Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer.
Elia EG; Städler N; Ciani O; Taylor RS; Bujkiewicz S
Cancer Epidemiol; 2020 Feb; 64():101665. PubMed ID: 31911395
[TBL] [Abstract][Full Text] [Related]
17. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
Tao JJ; Schram AM; Hyman DM
Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700
[TBL] [Abstract][Full Text] [Related]
18. Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models.
Bruno R; Chanu P; Kågedal M; Mercier F; Yoshida K; Guedj J; Li C; Beyer U; Jin JY
Br J Cancer; 2023 Oct; 129(9):1383-1388. PubMed ID: 36765177
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine in Oncology Pharmacy Practice.
Saadeh C; Bright D; Rustem D
Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
[TBL] [Abstract][Full Text] [Related]
20. Giving Up on Precision Oncology? Not So Fast!
Warner JL
Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
